Skip to main content
Equibles
NSP $46.29 -10.38%
NSP logo
NSP · Insperity, Inc.
Track NSP — free

Use NSP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NSP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$46.29 -5.36 (-10.38%) Earnings today Q2 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.97B
Shares
38.20M
Volume · Oct 29 704.64K Avg daily vol (3M) 445.85K
All webcasts

Earnings call · FY2025 Q2

Insperity, Inc. (NSP) Q2 2025 Earnings Call

Concluded Aug 1, 2025
Aug 1, 2025 0 turns
Period
FY2025 Q2
Runtime
—
Sources
2 artifacts
Revenue $1.66B +3.3% YoY
Diluted EPS -$0.14 -129.2% YoY
Gross margin 13.4% -2.8 pp YoY
Net income -$5.00M -127.8% YoY
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Workday strategic partnership and HRScale 39 2026 profitability recovery plan 25 UHC contract renewal 15 Worksite employee growth 15 Elevated benefits and health care costs 10 Operating expense and capital management 9

Management tone

Positive

Net tone +15 · moderate hedging

Grounding quotes
  • “Despite our reported Q2 results and the lower guidance for this year, we remain confident in our outlook for accelerated growth and improved profitability in 2026.”
  • “These results fell slightly under the low end of our forecasted range by $0.03 per share and $1 million, respectively, primarily due to a continuation of higher-than-expected benefits costs.”
  • “The highlight of the first half of 2025 is the resilience, agility and focus on sales and retention amid a complex and shifting market landscape.”
  • “We have not seen further deterioration in claim development related to older periods like we did in Q1, and we have seen some indications that the previously discussed acceleration in inpatient and outpatient service utilization has moderated somewhat but remains elevated.”

Forward guidance

4 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 1, 2025 10-Q report Filed Aug 1, 2025

Forward guidance

From the 8-K filed Aug 1, 2025.

Metric Guided
Adjusted EPS table
Q3 2025
 $0.06 – $0.49
Adjusted EPS table
Full Year 2025
 $1.81 – $2.51
Adjusted EBITDA (in millions) table
Full Year 2025
 $170M – $205M
Adjusted EBITDA (in millions) table
Q3 2025
 $24M – $44M

Quarter detail

How the reported period landed and where the business moved.

Revenue · regions

Northeast$452.00M +3.4% YoY
West$339.00M +3% YoY
Southwest$311.00M +2.3% YoY
Central$301.00M +3.1% YoY
Southeast$238.00M +5.8% YoY
Other Revenues$17.00M -5.6% YoY

Capital returned

Dividend / share
$0.60
Full-screen source Call document

NSP alerts

Insperity, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →